Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

This is a Phase II, randomized, observer-blind, placebo-controlled, multi-site trial of the FDA licensed rMenB+OMV NZ vaccine, Bexsero. The targeted study population is men and women 18-50 years

  • 0 views
  • 16 Sep, 2021
  • 7 locations
A Sourcing Study to Collect Human Blood Samples From Healthy Adults

against meningitis- MenACWY vaccine (Menveo) or rMenB+OMV NZ vaccine (Bexsero), which will serve for the development, qualification, validation and maintenance of immunological assays and will support the

hysterectomy
bexsero
menacwy
menveo
vaccination
  • 731 views
  • 26 Jan, 2021
  • 7 locations
GlaxoSmithKline's (GSK) Safety and Immunogenicity Study of GSK Meningococcal Group B and 13-valent Pneumococcal Vaccines Administered Together With Routine Infant Vaccines in Healthy Infants

The purpose of this study is to evaluate the safety and immunogenicity of Bexsero (meningococcal group B vaccine-rMenB+OMV NZ) in North American infants 6 weeks through 12 months of age, when

pneumococcal
conjugate vaccine
bexsero
varivax
hiberix
  • 112 views
  • 12 Jun, 2021
  • 43 locations
Study to Assess Effectiveness of GlaxoSmithKline's (GSK's) Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults.

The purpose of this study is to evaluate the effectiveness of 2 doses or 3 doses of GSK's licenced meningococcal group B Bexsero (rMenB+OMV NZ) vaccine and of 2 doses of GSK's investigational

conjugate vaccine
bexsero
vaccination
menacwy
  • 21 views
  • 01 May, 2021
  • 101 locations
Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults Adolescents Toddlers and Infants

only) To describe the safety profile of the SP MenB vaccine formulations, Bexsero Vaccine and Trumenba Vaccine in healthy adults, and adolescents; To describe the safety

  • 0 views
  • 07 Jul, 2021
  • 21 locations
Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination

This is a Phase 2 mechanistic clinical trial to assess the systemic and mucosal immunogenicity of the multicomponent meningococcal serogroup B vaccine (4CMenB or Bexsero (R)) (group 1, 40

  • 0 views
  • 23 Jul, 2021
  • 1 location
Efficacy Study of 4CMenB (Bexsero ) to Prevent Gonorrhoea Infection in Gay and Bisexual Men

This is a Phase 3, double-blinded, randomised placebo-controlled, multi-centred trial evaluating the efficacy of the four-component meningococcal B vaccine, 4CMenB (Bexsero), in the prevention

  • 0 views
  • 22 Jul, 2021
  • 4 locations
  • 0 views
  • 25 Mar, 2021
  • 9 locations
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom

titer 1:8) when MenACYW conjugate vaccine is administered concomitantly with Bexsero in the second year of life compared to when MenACYW conjugate vaccine is given alone The secondary objective is to

meningococcal conjugate
whooping cough
rotavirus
poliomyelitis
diphtheria
  • 2 views
  • 04 Jul, 2021
  • 25 locations
Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV

receiving antiretroviral treatment. Participants are randomized 1:1 to either a two-dose Menveo and Bexsero regimen or a Prevenar13/Pneumovax23 prime-boost regimen at day 0 and day 60 and cross over

  • 0 views
  • 12 May, 2021
  • 1 location